𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Screening for new agents

✍ Scribed by B. Öberg; L. Vrang

Publisher
Springer
Year
1990
Tongue
English
Weight
647 KB
Volume
9
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-specific antigen: A surrogate e
Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?
✍ Schr�der, Fritz H.; Kranse, Ries; Barbet, Nik; Hop, Wim C.J.; Kandra, Albert; La 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 2 views

BACKGROUND. An endpoint for clinical trials of prostate cancer which simplifies traditional endpoints (response of measurable lesions, progression rates, and death) is urgently needed. This is especially true for hormone-unresponsive disease, for which many new drugs are presently in a development p

Two models for screening chelating agent
Two models for screening chelating agents for cadmium removal
✍ Waltraud Rau; Felicitas Planas-Borne; David M. Taylor 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 503 KB

The effectiveness of some chelating agents to mobilize cadmium from Chinese hamster ovary cells after chronic exposure (20 hr), as well as from cytosolic metallothionein, was studied. In the first protocol the most effective substance was 2,3-dimercaptopropanol, followed by 2,3-dimercaptopropane-l-s